Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Passmore

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
The Cochrane Database of Systematic Reviews|January 5, 2016
Statins for the prevention of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
Sleep|September 2, 2006
Genetically increased risk of sleep disruption in Alzheimer's diseaseDavid Craig, Dominic J Hart, A Peter Passmore
Drugs & Aging|December 7, 2014
Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility studyCarole Parsons, Laura McCann, Peter Passmore, et al.
Journal of the Neurological Sciences|March 12, 2005
Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trialsA Peter Passmore, Anthony J Bayer, Elisabeth Steinhagen-Thiessen
International Journal of Geriatric Psychiatry|March 26, 2013
Survival in dementia and predictors of mortality: a reviewStephen Todd, Stephen Barr, Mark Roberts, et al.
Age and Ageing|January 21, 2017
Pisa syndrome due to donepezil: pharmacokinetic interactions to blame?David Pollock, Emma Cunningham, Bernadette McGuinness, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 22, 2021
Factors influencing transition to care homes for people with dementia in Northern IrelandEvi Zafeiridi, Alan J McMichael, A Peter Passmore, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 13, 2006
Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's diseaseDavid Craig, Caroline Donnelly, Dominic Hart, et al.
Lancet (London, England)|October 7, 2004
AD2000: design and conclusionsClive Holmes, Alistair Burns, Peter Passmore, et al.
The Cochrane Database of Systematic Reviews|July 9, 2014
Statins for the treatment of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
The Cochrane Database of Systematic Reviews|January 5, 2016
Statins for the prevention of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
Sleep|September 2, 2006
Genetically increased risk of sleep disruption in Alzheimer's diseaseDavid Craig, Dominic J Hart, A Peter Passmore
Drugs & Aging|December 7, 2014
Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility studyCarole Parsons, Laura McCann, Peter Passmore, et al.
Journal of the Neurological Sciences|March 12, 2005
Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trialsA Peter Passmore, Anthony J Bayer, Elisabeth Steinhagen-Thiessen
International Journal of Geriatric Psychiatry|March 26, 2013
Survival in dementia and predictors of mortality: a reviewStephen Todd, Stephen Barr, Mark Roberts, et al.
Age and Ageing|January 21, 2017
Pisa syndrome due to donepezil: pharmacokinetic interactions to blame?David Pollock, Emma Cunningham, Bernadette McGuinness, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 22, 2021
Factors influencing transition to care homes for people with dementia in Northern IrelandEvi Zafeiridi, Alan J McMichael, A Peter Passmore, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 13, 2006
Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's diseaseDavid Craig, Caroline Donnelly, Dominic Hart, et al.
Lancet (London, England)|October 7, 2004
AD2000: design and conclusionsClive Holmes, Alistair Burns, Peter Passmore, et al.
The Cochrane Database of Systematic Reviews|July 9, 2014
Statins for the treatment of dementiaBernadette McGuinness, David Craig, Roger Bullock, et al.
Pageof 14